NRMGX
Price
$16.60
Change
-$0.31 (-1.83%)
Updated
May 6 closing price
Net Assets
1.81B
PMAQX
Price
$44.74
Change
-$0.42 (-0.93%)
Updated
May 6 closing price
Net Assets
30.18B
Ad is loading...

NRMGX vs PMAQX

Header iconNRMGX vs PMAQX Comparison
Open Charts NRMGX vs PMAQXBanner chart's image
Neuberger Berman Mid Cap Growth R6
Price$16.60
Change-$0.31 (-1.83%)
VolumeN/A
Net Assets1.81B
Principal MidCap R6
Price$44.74
Change-$0.42 (-0.93%)
VolumeN/A
Net Assets30.18B
NRMGX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NRMGX vs. PMAQX commentary
May 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRMGX is a Buy and PMAQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 30.2B vs. NRMGX (1.81B). PMAQX pays higher dividends than NRMGX: PMAQX (0.20) vs NRMGX (0.00). NRMGX was incepted earlier than PMAQX: NRMGX (12 years) vs PMAQX (8 years). NRMGX (0.59) and PMAQX (0.59) have similar cost to investors . NRMGX is a more actively managed with annual turnover of: 97.00 vs. PMAQX (10.50). NRMGX (0) and PMAQX (0) have matching initial minimum investment requirements. PMAQX annual gain was more profitable for investors over the last year : 11.19 vs. NRMGX (2.05). PMAQX return over 5 years is better than : 74.20 vs. NRMGX (14.12).
NRMGXPMAQXNRMGX / PMAQX
Total Expense Ratio0.590.59100%
Annual Report Gross Expense Ratio0.590.59100%
Fund Existence12 years8 years-
Gain YTD-1.6271.322-123%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.81B30.2B6%
Annual Yield % from dividends0.000.20-
Returns for 1 year2.0511.1918%
Returns for 3 years16.6837.7144%
Returns for 5 years14.1274.2019%
Returns for 10 years16.13N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVS67.10-0.36
-0.53%
CVS HEALTH Corp
KBR51.57-0.51
-0.98%
KBR
NVCR17.76-0.39
-2.15%
NovoCure Limited
BNGO3.95-0.10
-2.47%
Bionano Genomics Inc
ABSI2.87-0.16
-5.28%
Absci Corp